Clinical Report: Atypical Meningococcemia: Diagnostic Lessons From a Fatal Case

Overview

This report discusses a fatal case of atypical meningococcemia caused by Neisseria meningitidis serogroup W, which presented with gastrointestinal symptoms rather than classic signs. The case highlights the importance of recognizing atypical presentations to ensure timely diagnosis and treatment.

Background

Invasive meningococcal disease can manifest without typical clinical features, complicating early diagnosis and delaying critical treatment. The emergence of serogroup W has been associated with atypical presentations, including gastrointestinal symptoms, which can lead to misdiagnosis. Understanding these atypical presentations is crucial for infectious disease clinicians to improve patient outcomes.

Data Highlights

No numerical data available in the source material.

Key Findings

• The patient presented with gastrointestinal symptoms, septic shock, and disseminated intravascular coagulation without a meningococcal rash.
• Rapidly progressive shock and severe lactic acidosis are characteristic of meningococcemia, regardless of skin manifestations.
• Chronic liver disease and splenic dysfunction are significant risk factors for invasive bacterial infections, including meningococcemia.
• Severe limb pain can be an early sign of invasive meningococcal disease.
• Empiric treatment with ceftriaxone should be initiated promptly when meningococcemia is suspected.
• Public health notification and chemoprophylaxis for close contacts are critical once meningococcal disease is suspected.

Clinical Implications

Clinicians should maintain a high index of suspicion for meningococcal disease in patients presenting with shock and coagulopathy, even in the absence of a rash. Prompt initiation of empiric antibiotic therapy is essential, particularly in patients with risk factors such as chronic liver disease.

Conclusion

This case underscores the necessity for clinical vigilance in recognizing atypical presentations of meningococcal disease to facilitate timely diagnosis and treatment. Early recognition of dangerous physiologic patterns is vital for improving patient outcomes.

References

1. CDC, Clinical Guidance for Meningococcal Disease, 2026 -- Current guidance emphasizes rapid recognition and empiric coverage.
2. Global Meningococcal Initiative, 2025 -- Consensus highlights atypical phenotypes of meningococcal disease.
3. Infection — Meningococcal CSF infection confirmed by PCR in the absence of pleocytosis, accompanied by elevated IL-6 and IL-8 levels
4. Open Forum Infectious Diseases — Unmasking Lomentospora prolificans: A Case Study of Fungemia with Diagnostic Challenges
5. Infection — Surprising Co-Infections Acquired in the Community During a Continuing Pandemic: An Overabundance of Concurrent Diagnoses
6. Infection — Severe Neurological Complications Linked to Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
7. Clinical Guidance for Meningococcal Disease | Meningococcal | CDC
8. Current global trends in meningococcal disease control, risk groups and vaccination_ Consensus of the Global Meningococcal Initiative
9. Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2025 | MMWR
10. Public Health Strategies for Antibiotic-resistant Neisseria meningitidis | Meningococcal | CDC
11. Clinical Overview of Meningococcal Disease | Meningococcal | CDC